Today is the last day to bid for Ventive Hospitality Limited, Senores Pharmaceuticals Limited and Carraro India Limited. In the last two trading days, Ventive Hospitality’s IPO was subscribed a total of 1.35 times. In the retail category, this issue was subscribed the most by 1.88 times. Along with this, it was subscribed 1.28 times in the Qualified Institutional Buyers (QIB) category and 1.13 times in the Non-Institutional Investors (NII) category. At the same time, the IPO of Senores Pharmaceuticals has been subscribed a total of 14.75 times so far. In the retail category, this issue was subscribed the most by 40.8 times. Along with this, it was subscribed 36% in the QIB category and 25.81 times in the NII category. Whereas, Carraro India’s IPO was subscribed only 23%. The issue was subscribed 37% in the retail category and 21% in the NII category. The IPOs of these three companies opened on 20 December. Their shares will be listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on 30 December. Let us know about the IPOs of these three companies one by one… 1. Ventive Hospitality Limited Ventive Hospitality Limited wants to raise a total of ?1,600 crore through the IPO. For this, the company is issuing 2,48,83,358 shares worth a total of ?1,600 crore. The existing investors of the company are not selling a single share. Retail investors can bid for a maximum of 299 shares. Ventive Hospitality Limited has fixed the price band of this issue as ?610-?643. Retail investors can bid for a minimum of one lot i.e. 23 shares. If you apply for 1 lot as per the IPO’s upper price band of ?643, then you will have to invest ?14,789 for it. At the same time, retail investors can apply for a maximum of 13 lots i.e. 299 shares. For this, investors will have to invest ?1,92,257 as per the upper price band. Ventive Hospitality’s premium in the grey market is 8.24% Before the IPO opened, the company’s stock has reached a premium of 8.24% i.e. ?53 per share in the grey market. In such a situation, as per the upper price band of ?643, its listing can happen at ?696. However, this is only an estimate, the listing price of the share is quite different from the grey market price. Ventive Hospitality Limited was established in February 2002. Ventive Hospitality Limited was established in February 2002 and is in the hospitality business. The company mainly develops and manages luxury hotels and resorts. As of September 30, 2024, the company has 11 hospitality assets in India and Maldives, which it was managing. The hospitality assets managed by Ventive Hospitality include hotels and resorts such as Marriott, Hilton, Minor and Atmosphere. As of September 30, 2024, the company had 2,791 permanent employees. 2. Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited wants to raise a total of ?582.11 crore through IPO. For this, the company is issuing 1,27,87,723 shares worth ?500 crore. The existing investors of the company are selling 21,00,000 shares worth ? 82.11 crore. Retail investors can bid for a maximum of 494 shares. Senores Pharmaceuticals Limited has fixed the price band of this issue as ? 372-? 391. Retail investors can bid for a minimum of one lot i.e. 38 shares. If you apply for 1 lot as per the IPO’s upper price band of ? 391, then you will have to invest ? 14,858 for it. On the other hand, retail investors can apply for a maximum of 13 lots i.e. 494 shares. For this, investors will have to invest ? 1,93,154 as per the upper price band. Senores Pharmaceuticals Limited was established in December 2017. Senores Pharmaceuticals Limited was established in December 2017, which is a global research-developed pharmaceutical company. The company manufactures pharmaceutical products primarily for the US, Canada and UK markets. The company’s product portfolio includes Amphetamine Sulfate Tablets, Hydroxychloroquine Sulfate Tablets, Ketoconazole Tablets, Butalbital, Acetaminophen and Caffeine Capsules, Mexiletine Hydrochloride Capsules, Ketorolac Tromethamine Tablets, Diclofenac Potassium Tablets, Diclofenac Potassium Tablets, Nicardipine Hydrochloride Capsules, Escitalopram Tablets, Prochlorperazine Maleate Tablets USP, Terazosin Capsules USP, Morphine Sulfate Tablets, Methadone Hydrochloride Tablets, Cyclobenzaprine Hydrochloride Tablets and Irbesartan Tablets among others. 3. Carraro India Limited
Carraro India Limited wants to raise a total of ?1,250 crore through IPO. For this, the existing investors of the company are selling 1,77,55,680 shares worth ?1,250 crore through Offer for Sale i.e. OFS. The company is not issuing a single fresh share for the IPO. Retail investors can bid for a maximum of 273 shares. Carraro India Limited has fixed the price band of this issue as ?668-?704. Retail investors can bid for a minimum of one lot i.e. 21 shares. If you apply for 1 lot as per the upper price band of IPO of ?704, then you will have to invest ?14,784 for it. At the same time, retail investors can apply for a maximum of 13 lots i.e. 273 shares. For this, investors will have to invest ? 1,92,192 as per the upper price band.
